Accueil / Tag Archives: Hospitals

Tag Archives: Hospitals

Gilead and Galapagos Announce Filgotinib Meets Primary and Key Secondary Endpoints in the Phase 3 FINCH 1 Rheumatoid Arthritis Study

Thursday, March 28th 2019 at 9:03pm UTC — Filgotinib 100 mg and 200 mg Doses Demonstrated Significantly Higher ACR20/50/70 Responses than Placebo in Patients with Prior Inadequate Methotrexate Response — — Significant Inhibition of Radiographic Progression Demonstrated with Both Doses of Filgotinib versus Placebo — — Safety Profile of Filgotinib …

Plus »

Gilead and Galapagos Report Updated Safety Information for Filgotinib in Rheumatoid Arthritis (RA)

Thursday, March 28th 2019 at 9:02pm UTC — Pooled Interim Phase 3 FINCH Program Data up to 24 Weeks and Phase 2b DARWIN 3 Long-Term Data Add to Evidence Supporting Filgotinib Safety Profile — FOSTER CITY, Calif. & MECHELEN, Belgium–(BUSINESS WIRE)– regulated information – Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext …

Plus »

Gilead and Galapagos Announce Filgotinib Meets Primary Endpoint in the Phase 3 FINCH 3 Study in Methotrexate-Naïve Rheumatoid Arthritis Patients

Thursday, March 28th 2019 at 9:04pm UTC — Filgotinib 100 mg and 200 mg Plus Methotrexate (MTX) Demonstrated Significantly Higher ACR20/50/70 Responses Than Methotrexate Alone — — Filgotinib Safety Profile Consistent With Previously Reported Results — FOSTER CITY, Calif. and MECHELEN, Belgium–(BUSINESS WIRE)– regulated information – Gilead Sciences, Inc. (NASDAQ: GILD) …

Plus »

Cytonus Therapeutics Announces Poster Presentation at the 2019 American Association for Cancer Research Annual Meeting

Thursday, March 28th 2019 at 8:04pm UTC SAN DIEGO–(BUSINESS WIRE)– Cytonus Therapeutics Inc., a biotechnology company developing new platforms for delivering biologics, announced today that it will be presenting preclinical data for its Cargocyte™ technology platform at the American Association for Cancer Research (AACR) annual meeting March 29 – April …

Plus »

Novus Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Clinical Updates

Thursday, March 28th 2019 at 12:00pm UTC IRVINE, Calif.–(BUSINESS WIRE)– Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced financial results for the quarter and year ended December 31, 2018 and provided updates …

Plus »

Prelude Fertility and Inception Establish the Largest Provider of Comprehensive Fertility Services in the U.S.

Thursday, March 28th 2019 at 11:15am UTC New Combined Company Will Dramatically Expand the Quality of Patient Experience and Best-in-Class Care NEW YORK–(BUSINESS WIRE)– Today, Prelude Fertility (Prelude) and Inception Fertility (Inception) announced a transaction establishing the Prelude Network as the fastest-growing network of fertility clinics, and now the largest …

Plus »

TransEnterix to Showcase Digital Laparoscopy with the Senhance Surgical System at Society of American Gastrointestinal and Endoscopic Surgeons 2019 Annual Meeting

Thursday, March 28th 2019 at 10:55am UTC RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)– TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery (MIS), today announced it will host several events highlighting digital laparoscopy with the Senhance™ Surgical …

Plus »

Gilead Launches HepConnect Initiative to Reduce Hepatitis C Infections in Greater Appalachia

Thursday, March 28th 2019 at 9:00am UTC — Funding will Expand Testing, Harm Reduction Services and Healthcare Infrastructure in States with Highest Infection Rates — — Harm Reduction Coalition Selected as Lead Grantee to Oversee 5-year Effort to Implement Proven Harm Reduction Strategies in Indiana, Kentucky, North Carolina, Tennessee and …

Plus »

American Renal Associates Holdings, Inc. Provides Update on Audit Committee Review and Announces Organizational Changes

Wednesday, March 27th 2019 at 8:15pm UTC Company to Restate Certain Financial Results Company Announces Resignation of Jason Boucher as Chief Financial Officer and Appointment of Mark Herbers as Interim Chief Financial Officer Company Remains Committed to Providing High Quality Care to Patients, Together with its Physician Partners BEVERLY, Mass.–(BUSINESS …

Plus »

EOS imaging Installs the First EOS® System in the United Arab Emirates

Wednesday, March 27th 2019 at 5:00pm UTC Located at the newly-inaugurated King’s College Hospital London in Dubai Hills PARIS–(BUSINESS WIRE)– Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI – Eligible PEA – PME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced installation of the first …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.